Management Change/Compensation Form 8 K

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Departure of Jan Hall

On September 17, 2024, Guardion Health Sciences, Inc. (the "Company") announced the termination of Janet ("Jan") Hall, its President and Chief Executive Officer, effective on October 17, 2024. As provided in her employment agreement, Ms. Hall is entitled to thirty days' notice of the Company's intention to terminate her employment. Accordingly, Ms. Hall will remain as an employee of the Company through October 17, 2024. Pursuant to the previously disclosed terms and conditions of Ms. Hall's employment agreement, including, without limitation, Ms. Hall's execution and non-revocation of a general release in favor of the Company and certain other parties, Ms. Hall will receive (i) severance in a total amount of approximately $400,000, less applicable withholdings and deductions payable as described in her employment agreement, and (ii) a transaction bonus of $300,000, less applicable withholdings and deductions, in connection of the Company's recent sale of its Viactiv® brand and business to Doctor's Best, Inc.

The Company expects to identify and announce an interim President and Chief Executive Officer prior to October 17, 2024.